Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is an important statement, IMHO.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Sorry to butt in, but you've lost me with your "concern".

First, how does a RS get PTSC more shares?

Second, shares are shares. They've got 500M authorized. There are at least 110M available for use. They need more?

And if the value of those shares are somehow diluted (get more authorized?), how does that make them a larger asset to leverage? The value of those shares, with dilution, would fundamentally decrease accordingly. Nothing gained.

I don't get it. But that's a hazzard when "just butting in".

SGE

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply